<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1911">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01651260</url>
  </required_header>
  <id_info>
    <org_study_id>5156-I</org_study_id>
    <nct_id>NCT01651260</nct_id>
  </id_info>
  <brief_title>Assessment of an Endotracheal Tube Securement Device</brief_title>
  <official_title>Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hollister Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hollister Incorporated</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endotracheal intubation is the translaryngeal placement of a tube into the trachea via the
      nose or mouth. Endotracheal tubes must be securely fixed to prevent movement, which may
      result in accidental slippage of the tube into a mainstream bronchus or into the pharynx.
      Hollister Incorporated is assessing the functionality and performance of an endotracheal
      tube securement device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was a multiple site assessment of the Anchor Fast with enhanced tube protection.
      Subjects already intubated who required a change of tube-securing device or subjects
      requiring intubation for greater than 24 hours who meet the inclusion and exclusion criteria
      were eligible to enroll into the study.The study was open to adult subjects without an
      existing neck injury who required oral tracheal intubation for greater than 24 hours.
      Subjects were required to have intact skin on the application site and to be free of facial
      hair, damaged skin or conditions on the application site (e.g. sunburn, scars, moles or
      other disfigurations), and significant skin diseases on the application site (e.g.
      psoriasis, eczema, atopic dermatitis, active cancer) which may have contraindicated
      participation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Prevention of Damage and/or Occlusion of Endotracheal (ET) Tube During Use</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of participants with damage of ET tube and Number of participants with occlusion of ET tube</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ease of Use</measure>
    <time_frame>Between 1 - 14 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Likert scale score provided by clinician (1 very difficult, 2 difficult, 3 neither easy nor difficult, 4 easy, 5 very easy);</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>Endotracheal (ET) tube securement device</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single arm study evaluated an experimental ET tube securement device with a bite block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental ET Tube Securement Device</intervention_name>
    <description>Experimental Hollister device with bite block was substituted for standard-of-care device during the study period.</description>
    <arm_group_label>Endotracheal (ET) tube securement device</arm_group_label>
    <other_name>AnchorFast GuardÂ® ET tube securement device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Is 18 years of age or older; male or female and requiring oral tracheal intubation.

          -  Has intact skin on application site.

          -  Willingly signs or their authorized representative willingly signs the Informed
             Consent.

          -  Is qualified to participate in the opinion of the Investigator.

        Exclusion Criteria:

          -  Has an existing neck injury.

          -  Has protruding upper teeth, without teeth or is unable to wear upper dentures.

          -  Has facial hair.

          -  Has clinically significant skin diseases on the application site which may
             contraindicate participation, including psoriasis, eczema, atopic dermatitis, active
             cancer.

          -  Has damaged skin or conditions on the application site which includes sunburn, scars,
             moles or other disfiguration of the test site.

          -  Has a known or stated allergy to adhesive bandages, or any of the product types being
             tested.

          -  Uses of topical drugs on the application site.

          -  Uses lotions, creams or oils on the application site.

          -  Currently is participating in any clinical testing which may affect performance of
             this device.

          -  Has been previously intubated with skin irritation or pressure sores surrounding the
             mouth.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth Konz, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hollister Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medstar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospitals</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Good Samaritan</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Salmon Creek Medical Center</name>
      <address>
        <city>Vancouver</city>
        <state>Washington</state>
        <zip>98686</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <lastchanged_date>February 23, 2016</lastchanged_date>
  <firstreceived_date>July 16, 2012</firstreceived_date>
  <firstreceived_results_date>March 18, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited between July 2012 to February 2013 in the ICU setting at 6 hospitals.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Hollister ET Tube Securement Device</title>
          <description>Hollister endotracheal tube securement device : Subjects wear one Hollister ET tube securement device until the device either needs to be changed or is no longer required by the subject.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>unable to apply product</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Complete demographic profiles were obtained for 63 participants</population>
      <group_list>
        <group group_id="B1">
          <title>Hollister ET Tube Securement Device</title>
          <description>Hollister endotracheal tube securement device: Subjects wear one Hollister ET tube securement device until the device either needs to be changed or is no longer required by the subject.</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="63"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="57.8" spread="15.6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="35"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Reason for intubation</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Respiratory Failure</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="55"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Post-operative</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Other</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="5"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Prevention of Damage and/or Occlusion of Endotracheal (ET) Tube During Use</title>
        <description>Number of participants with damage of ET tube and Number of participants with occlusion of ET tube</description>
        <time_frame>14 days</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Hollister Endotracheal (ET) Tube Securement Device</title>
            <description>Hollister endotracheal tube securement device : Subjects wear one Hollister ET tube securement device until the device either needs to be changed or is no longer required by the subject.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="62"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Prevention of Damage and/or Occlusion of Endotracheal (ET) Tube During Use</title>
            <description>Number of participants with damage of ET tube and Number of participants with occlusion of ET tube</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Damage to ET tube</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Occlusion of ET Tube</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <param_type>upper probability of failure</param_type>
            <param_value>.05</param_value>
            <estimate_desc>Minimum sample size of 60 subjects was required based on the ability of the device to perform at an observed level of non-failure equivalent to an expected upper probability of failure not to exceed 5%.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ease of Use</title>
        <description>Likert scale score provided by clinician (1 very difficult, 2 difficult, 3 neither easy nor difficult, 4 easy, 5 very easy);</description>
        <time_frame>Between 1 - 14 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Hollister ET Tube Securement Device</title>
            <description>Hollister endotracheal tube securement device : Subjects wear one Hollister ET tube securement device until the device either needs to be changed or is no longer required by the subject.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="62"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ease of Use</title>
            <description>Likert scale score provided by clinician (1 very difficult, 2 difficult, 3 neither easy nor difficult, 4 easy, 5 very easy);</description>
            <units>% rating with score of 4 and 5</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Hollister ET Tube Securement Device</title>
          <description>Hollister endotracheal tube securement device: Subjects wear one Hollister ET tube securement device until the device either needs to be changed or is no longer required by the subject.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Loosened teeth</sub_title>
                <description>Three upper teeth loose. Probably related to device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="65"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <description>Patient on terminal wean expired with device in place. Unrelated to device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="65"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <description>Patient on terminal wean expired with device in place. Unrelated to device</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Obstruction of ET tube</sub_title>
                <description>Blood oxygen saturation (SpO2) dropped from 100% to 60% due to patient biting ET tube. Unrelated to the device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ulcer on tongue</sub_title>
                <description>Ulcer on tongue possibly related to device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
              </event>
              <event>
                <sub_title>Upper lip breakdown</sub_title>
                <description>Upper lip ulcer probably related to device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
              </event>
              <event>
                <sub_title>Wound on upper palette</sub_title>
                <description>Wound on upper palette probably related to device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
              </event>
              <event>
                <sub_title>Bleeding tongue.</sub_title>
                <description>Patient forced tongue to opposite side of jaw and bit the tongue. Unrelated to the device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Adult subjects in respiratory insufficiency in ICU setting were intubated with only four ET tube sizes: 7.0, 7.5, 8.0 and 8.5 mm. No other sizes were represented in the sample population.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Malford Cullum</name_or_title>
      <organization>Hollister Incorporated</organization>
      <phone>847-918-3975</phone>
      <email>malford.cullum@Hollister.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
